Cyclo Therapeutics Inc [NASDAQ: CYTH] gained 54.55% or 0.42 points to close at $1.19 with a heavy trading volume of 84274415 shares.
The daily chart for CYTH points out that the company has recorded 2.59% gains over the past six months.
If we look at the average trading volume of 45.40K shares, CYTH reached to a volume of 84274415 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Cyclo Therapeutics Inc [CYTH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CYTH shares is $4.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CYTH stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Cyclo Therapeutics Inc is set at 0.11, with the Price to Sales ratio for CYTH stock in the period of the last 12 months amounting to 39.14.
Trading performance analysis for CYTH stock
Cyclo Therapeutics Inc [CYTH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 54.55. With this latest performance, CYTH shares gained by 83.08% in over the last four-week period, additionally plugging by 2.59% over the last 6 months – not to mention a drop of -34.46% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CYTH stock in for the last two-week period is set at 78.54, with the RSI for the last a single of trading hit 83.16, and the three-weeks RSI is set at 74.31 for Cyclo Therapeutics Inc [CYTH]. The present Moving Average for the last 50 days of trading for this stock 0.6924, while it was recorded at 0.8633 for the last single week of trading, and 0.9482 for the last 200 days.
Cyclo Therapeutics Inc [CYTH]: A deeper dive into fundamental analysis
Cyclo Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.16 and a Current Ratio set at 0.17.
An analysis of Institutional ownership at Cyclo Therapeutics Inc [CYTH]
There are presently around $13.17%, or 21.98%% of CYTH stock, in the hands of institutional investors.
